Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 33 | 33 |
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 17 | 17 |
| 1998 | 0 | 28 | 28 |
| 1999 | 0 | 30 | 30 |
| 2000 | 0 | 23 | 23 |
| 2001 | 1 | 33 | 34 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 34 | 34 |
| 2004 | 1 | 40 | 41 |
| 2005 | 1 | 30 | 31 |
| 2006 | 1 | 21 | 22 |
| 2007 | 1 | 42 | 43 |
| 2008 | 1 | 47 | 48 |
| 2009 | 1 | 44 | 45 |
| 2010 | 0 | 45 | 45 |
| 2011 | 0 | 38 | 38 |
| 2012 | 0 | 35 | 35 |
| 2013 | 1 | 37 | 38 |
| 2014 | 0 | 33 | 33 |
| 2015 | 1 | 25 | 26 |
| 2016 | 0 | 40 | 40 |
| 2017 | 0 | 39 | 39 |
| 2018 | 1 | 37 | 38 |
| 2019 | 1 | 41 | 42 |
| 2020 | 0 | 33 | 33 |
| 2021 | 0 | 24 | 24 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 13 | 13 |
| 2024 | 0 | 22 | 22 |
| 2025 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference. Oncoimmunology. 2025 Dec; 14(1):2507856.
-
Intraarterial Thrombolysis as an Adjunct to Thrombectomy in Acute Ischemic Stroke: Current Status and Future Prospects. J Neuroimaging. 2025 Mar-Apr; 35(2):e70030.
-
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. Lancet Oncol. 2025 Mar; 26(3):e152-e170.
-
Multimodal Therapy May be Key to Improving Survival for Octogenarians Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: An American Multicenter Analysis. Ann Surg Oncol. 2025 May; 32(5):3582-3592.
-
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Jan; 23(1).
-
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference. Oncoimmunology. 2025 Dec; 14(1):2432726.
-
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation. J Surg Oncol. 2025 Apr; 131(5):810-815.
-
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol. 2024 Dec; 42(34):4095-4102.
-
Invasive Treatment Strategy for Older Patients with Myocardial Infarction. N Engl J Med. 2024 11 07; 391(18):1673-1684.